2024-03-07
Each shipment must be accompanied by a zoosanitary export certificate endorsed by an official veterinarian of the country of origin attesting to the following conditions:
The finished processed pet supplements as described in the veterinary export certificate have been prepared and stored in a plant approved and supervised by the competent veterinary authority
The supplement does not contain any of the following ingredients : meat, organs, offal, bone or meat meal, bone broth, spray dried plasma or other blood derivatives (including blood meal), or products of a rendering plant (fish oil and green lipped mussel powder excepted)
The exported product contains the following animal origin ingredients (for point 3, delete as appropriate):
Gelatin and/or collagen derived from the following species: porcine, piscine, equine, ovine, or caprine
Bovine derived gelatin and/or collagen
b1. Is derived from hides/skins
and/or
b2. Is derived from bones of bovines originating in region(s) recognized by World Organisation for Animal Health (WOAH) as negligible risk for bovine spongiform encephalopathy (BSE)
and/or
b3. Is derived from bones of bovines originating in region(s) recognized by WOAH as controlled risk for BSE
and
b3a) The bones were derived from bovines that passed ante and post mortem inspection
b3b) The bones did not include the skulls of bovines or the vertebral column of bovines 30 months of age or older
b3c) The bones were subjected to a process that includes all of the following steps:
degreasing
acid demineralization
acid or alkaline treatment
filtration
sterilization at 138°C (280°F) or greater for a minimum of 4 seconds
Egg phospholipid or egg lecithin, spray-dried egg, or other egg ingredients
c1. The egg ingredients originate from a country or zone recognized by Canada as free of Highly Pathogenic Avian Influenza and Virulent Newcastle Disease
or
c2. The egg ingredients have been processed in a manner sufficient to inactivate highly pathogenic avian influenza and virulent Newcastle disease viruses in accordance with the recommendations of the WOAH Terrestrial Animal Health Code
Marine-origin material of finfish, mollusc and crustacean, including fish/krill oils, green lipped mussel, freeze dried shellfish, and dehydrated fish. Only fish oils and green lipped mussel powder are acceptable products of a rendering plant. If used as an ingredient, powder made from green lipped mussel has a moisture content of <10%.
Lactose or lactose derivatives
Other milk or milk products
f1. The milk ingredient was produced in __________ [name of country or region], a country or region recognized by Canada as free of foot-and-mouth disease (FMD). The milk/milk product has never been in any country or region which Canada does not recognize as free of FMD, except when moving under seal.
or
f2. The milk ingredient was produced in __________ [name of country or region], a country or region not recognized by Canada as free of foot-and-mouth disease (FMD). It has been subjected to the following treatments:
pasteurization: minimum of 72 degrees Celsius for at least 15 seconds, or
ultra-High temperature (UHT): minimum of 140 degrees Celsius for at least 5 seconds, or
low final pH (less than 6) for a period of 1 hour, and
followed by a second treatment from the above, and
every precaution was taken to prevent contamination of the product after completion of the processing with anything of a lesser status
Vitamin D3 derived from sheep wool grease / lanolin
Vitamin A coated with porcine gelatin
Beeswax, royal jelly, or other bee-derived material
Bovine dicalcium phosphate
j1. The dicalcium phosphate contains no trace of protein or fat
or
j2. The dicalcium phosphate originates from a region recognized by WOAH as negligible risk for BSE (__________) (name of the region)
or
j3. The dicalcium phosphate originates from a region recognized by WOAH as controlled risk for BSE (__________) (name of the region), is derived from bovines that have passed ante-mortem and post-mortem inspections, and does not contain Specified Risk Material (SRM)Footnote *
Bovine tallow and/or tallow derivatives
k1. Meets the definition of tallow derivative: any chemical obtained through initial hydrolysis, saponification, or transesterification of tallow; chemical conversion of material obtained by hydrolysis, saponification, or transesterification may be applied to obtain the desired product
or
k2. Contains a maximum level of insoluble impurities of 0.15% by weight
or
k3. Contains greater than 0.15% insoluble impurities by weight and originates from a region recognized by WOAH as negligible risk for BSE
or
k4. Contains greater than 0.15% insoluble impurities by weight and originates from a region of controlled risk for BSE, is derived from bovines that have passed ante-mortem and postmortem inspections, and has not been prepared using Specified Risk Material (SRM)Footnote *
Every precaution was taken to prevent cross-contamination of the finished product with any animal origin product or by-product derived from animals of a lesser zoosanitary status
The supplements have been packaged in new packaging that clearly indicates their intended use
Footnote 1
SRM includes the following list:
From Controlled Risk Countries:
the distal ileum of the small intestine and the tonsils from bovines of any age, and
brain, skull, eyes, trigeminal ganglia, spinal cord, dorsal root ganglia, and vertebral column (excluding the vertebrae of the tail, the transverse processes of the thoracic and lumbar vertebrae, and the wings of the sacrum) from bovines 30 months of age and older
Each shipment must be accompanied by a zoosanitary export certificate endorsed by an official veterinarian of the country of origin attesting to the following conditions:
The finished processed pet supplements as described in the veterinary export certificate have been prepared and stored in a plant approved and supervised by the competent veterinary authority
The exported product contains the following animal origin ingredients (for point 2, delete as appropriate):
Gelatin and/or collagen derived from the following species: porcine, piscine, equine, ovine, or caprine
Bovine derived gelatin and/or collagen
b1. Is derived from hides/skins
and/or
b2. Is derived from bones of bovines originating in region(s) recognized by WOAH as negligible risk for BSE
and/or
b3. Is derived from bones of bovines originating in region(s) recognized by WOAH as controlled risk for BSE
and
b3a) The bones were derived from bovines that passed ante and post mortem inspection
b3b) The bones did not include the skulls of bovines or the vertebral column of bovines 30 months of age or older
b3c) The bones were subjected to a process that includes all of the following steps:
degreasing
acid demineralization
acid or alkaline treatment
filtration
sterilization at 138°C (280°F) or greater for a minimum of 4 seconds
Egg phospholipid or egg lecithin, spray-dried egg, or other egg ingredients
c1. The egg ingredients originate from a country or zone recognized by Canada as free of Highly Pathogenic Avian Influenza and Virulent Newcastle Disease
or
c2. The egg ingredients have been processed in a manner sufficient to inactivate highly pathogenic avian influenza and virulent Newcastle disease viruses in accordance with the recommendations of the WOAH Terrestrial Animal Health Code
Marine-origin material of finfish, mollusc and crustacean, including fish/krill oils, green lipped mussel, freeze dried shellfish, and dehydrated fish. Only fish oils and green lipped mussel powder are acceptable products of a rendering plant. If used as an ingredient, powder made from green lipped mussel has a moisture content of <10%.
Lactose or lactose derivatives
Other milk or milk products
f1.The milk ingredient was produced in __________ [name of country or region], a country or region recognized by Canada as free of foot-and-mouth disease (FMD). The milk/milk product has never been in any country or region which Canada does not recognize as free of FMD, except when moving under seal.
or
f2. The milk ingredient was produced in __________ [name of country or region], a country or region not recognized by Canada as free of foot-and-mouth disease (FMD). It has been subjected to the following treatments:
pasteurization: minimum of 72 degrees Celsius for at least 15 seconds, or
ultra-High temperature (UHT): minimum of 140 degrees Celsius for at least 5 seconds, or
low final pH (less than 6) for a period of 1 hour, and
followed by a second treatment from the above, and
every precaution was taken to prevent contamination of the product after completion of the processing with anything of a lesser status
Vitamin D3 derived from sheep wool grease / lanolin
Vitamin A coated with porcine gelatin
Beeswax, royal jelly, or other bee-derived material
Bovine dicalcium phosphate
j1. The dicalcium phosphate contains no trace of protein or fat
or
j2. The dicalcium phosphate originates from a region recognized by WOAH as negligible risk for BSE (__________) (name of the region)
or
j3. The dicalcium phosphate originates from a region recognized by WOAH as controlled risk for BSE (__________) (name of the region), is derived from bovines that have passed ante-mortem and post-mortem inspections, and does not contain SRMsFootnote *
Bovine tallow and/or tallow derivatives
k1. Meets the definition of tallow derivative: any chemical obtained through initial hydrolysis, saponification, or transesterification of tallow; chemical conversion of material obtained by hydrolysis, saponification, or transesterification may be applied to obtain the desired product
or
k2. Contains a maximum level of insoluble impurities of 0.15% by weight
or
k3. Contains greater than 0.15% insoluble impurities by weight and originates from a region recognized by WOAH as negligible risk for BSE
or
k4. Contains greater than 0.15% insoluble impurities by weight and originates from a region of controlled risk for BSE, is derived from bovines that have passed ante-mortem and postmortem inspections, and has not been prepared using Specified Risk Material (SRMFootnote *)
Spray dried plasma of porcine origin
l1. The plasma originates from a country or zone recognized by Canada as free from African Swine Fever, Classical Swine Fever, Foot-and-Mouth Disease, and Swine Vesicular Disease
and
l2. The plasma originates from animals that passed ante-mortem and post-mortem inspection
and
l3. The plasma was heat treated to at least 80º Celsius throughout its substance
Blood meal of bovine and/or porcine origin
m1. The blood meal originates from animals that passed ante-mortem and post-mortem inspection, was collected at [name and slaughter establishment number or numbers] and processed at __________ [name and address of processing plant].
and/or
m2. If bovine,
m2a. The animals from which the blood was derived were killed using a non-penetrative method, in accordance with humane slaughter practices, or
m2b. Were exclusively under 30 months of age at the time of slaughter, or
m2c. Using a system whereby each head is trimmed, washed, or scraped to remove grossly visible brain material and the stun hole is plugged with edible grease to prevent neural leakage.
and
m3. The blood meal has been subjected to a heat treatment of at least 80º Celsius for 30 minutes
Organ and offal meat
n1. The meat originates from animals that passed ante mortem and post mortem inspection
and
n2. The meat has been subjected to a heat treatment of at least 70 º Celsius for 30 minutes
or
n3. Meat ingredients have been processed in a manner sufficient to inactivate all diseases of concern to CanadaFootnote ** to which the donor animal(s) is susceptible, in accordance with the recommendations of the WOAH Terrestrial Animal Health Code
or
n4. Unprocessed (non heat treated) meat ingredients originate from animals that were raised, slaughtered, and processed in a country or zone recognized by Canada as free from all diseases of concernFootnote ** to which the donor animal(s) is susceptible
Bone meal and bone broth of avian origin
o1.Is derived from birds that passed ante mortem and post mortem inspection
and
o2.Originates from and was processed in a country or zone recognized by Canada as free of Highly Pathogenic Avian Influenza and Virulent Newcastle Disease
or
o3. Has been processed in a manner sufficient to inactivate highly pathogenic avian influenza and virulent Newcastle disease viruses in accordance with the recommendations of the WOAH Terrestrial Animal Health Code
Meat and bone meal, bone meal, bone broth, and other rendered ingredients of ruminant origin were legally imported from only Australia and/or New Zealand
Every precaution was taken to prevent cross-contamination of the finished product with any animal origin product or by-product derived from animals of a lesser zoosanitary status
The supplements have been packaged in new packaging that clearly indicates their intended use
Animal origin ingredients have been processed in a manner sufficient to inactivate all diseases of concern to CanadaFootnote ** to which the donor animal(s) is susceptible, in accordance with the recommendations of the WOAH Terrestrial Animal Health Code
Footnote 1
SRM includes the following list:
From Controlled Risk Countries:
the distal ileum of the small intestine and the tonsils from bovines of any age, and
brain, skull, eyes, trigeminal ganglia, spinal cord, dorsal root ganglia, and vertebral column (excluding the vertebrae of the tail, the transverse processes of the thoracic and lumbar vertebrae, and the wings of the sacrum) from bovines 30 months of age and older
Footnote 2
Diseases of concern for Canada for animal products and by-products covered by this certificate are:
For avian species including poultry:
Highly Pathogenic Avian Influenza
Newcastle disease
For ruminants:
Contagious bovine pleuropneumonia
Foot-and-mouth disease (FMD)
Lumpy skin disease
Rift valley fever
peste des petits ruminants (PDPR)
Sheep pox
goat pox
For swine:
African swine fever
Classical swine fever (Hog cholera)
Foot and Mouth Disease
Swine vesicular disease
For Horses and other equids:
African horse sickness
For lagomorphs (Commercially reared):
rabbit viral haemorrhagic disease
myxomatosis